BlueCrest Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

BlueCrest Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,359	Closed	-$499K	–	700
2019 Q3	$499K	Buy	+7,359	New	+$505K	0.03%	264

BlueCrest Capital Management's GHDX Position: Q4 2019 in Review

BlueCrest Capital Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 7,359 shares — an estimated $499K sold.

BlueCrest Capital Management first reported a position in GHDX in Q3 2019 and held it in 1 quarter. The position peaked at $499K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

BlueCrest Capital Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
BlueCrest Capital Management sold 7,359 Genomic Health, Inc. shares in Q4 2019, an estimated $499K.
BlueCrest Capital Management first reported a position in Genomic Health, Inc. in Q3 2019 and held it in 1 quarter.
BlueCrest Capital Management's Genomic Health, Inc. position peaked at $499K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on BlueCrest Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.